Crossref DOIMemberCiteFactoropen accessissn
SJIF Impact Factor 8.659 | ISSN: 2582-3930
IJSREM Logo

International Journal of Scientific Research in Engineering and Management

(Gateway to Global Scholars - An International, Scholarly, Multi-Disciplinary, Open Access Journal)

Peer-Reviewed Journal Designed to Meet UGC's Quality Parameters

HomeCurrent IssuePast IssuesPay OnlineConferencesEditorial BoardAbout UsContact Us
IJSREM

Loading article...

Follow Us

  • Google Scholar
  • ResearchGate
  • Academia.edu
  • Mendeley
  • LinkedIn
  • Facebook
  • Instagram

Journal Policies

  • Peer Review Policy
  • Publication Ethics
  • Copyright Infringement
  • Refund & Cancellation Policy
  • Terms and Conditions
  • Privacy Policy

Journal Identifiers & Licenses

  • ISSN Verified: 2582-3930ISSN Verified: 2582-3930
  • Crossref DOI: 10.55041Crossref DOI: 10.55041
  • SJIF Ranking: 08.659SJIF Ranking: 08.659
  • Licensed under CC BY 4.0Licensed under CC BY 4.0
  • ISO Certification: 9001:2015ISO Certification: 9001:2015
  • Indexed & Cited In: Google ScholarIndexed & Cited In: Google Scholar

Contact Us

International Journal of Scientific Research in Engineering and Management (IJSREM)

#62/1, New No 7, 1st Cross, 2nd Main, Ganganagar, R T Nagar, Bangalore North, Bangalore, Karnataka, India – 560032
[email protected]+91 93911 67991
logos
logos
Working Hours

Mon – Sat: 9:00 AM – 6:00 PM

Sunday: 10:00 AM – 4:00 PM

+91 93911 67991

© 2026 IJSREM – International Journal of Scientific Research in Engineering and Management. This is an open-access journal. Articles are published under the Creative Commons Attribution (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

DisclaimerPrivacy PolicyTerms and Conditions
ArticlePeer ReviewedOpen AccessPlagiarism Passed
Paper ID:IJSREM16058

Explainable Multimodal Deep Learning Framework for Early Alzheimer's Disease Detection Using MRI and Genomic Data

Stream/Area:

-

Subject:

-

Paper ID:

IJSREM16058

Volume:

6 |

8 |

Aug 2022

Pages:

1-5

Publication Frequency:

Monthly (12 issues per year)

DOI
Digital Object Identifier
10.55041/IJSREM16058

License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.

Share this article:

Authors

NVG

Naga Venkatesh Gangabathula

MS in Computer Science

Souther Illinois University

Download Author Certificate

Author Services & Downloads

Full ArticlesAcceptance Certificate

Abstract

Alzheimer's Disease (AD) affects over 55 million people globally, with early detection remaining a critical challenge due to subtle preclinical biomarkers and heterogeneous disease progression. Traditional diagnostic approaches rely on unimodal clinical assessments or isolated neuroimaging, limiting sensitivity to early-stage pathological changes. We propose an Explainable Multimodal Deep Learning Framework (EMDL-AD) that integrates structural MRI volumetrics with genomic risk profiles using a novel attention-fusion architecture. Our framework employs three analytically distinct components: (1) a Dual-Stream Feature Encoder that extracts hierarchical representations from 3D MRI scans and polygenic risk scores; (2) a Cross-Modal Attention Fusion Module that dynamically weights modality-specific contributions based on patient-specific uncertainty; and (3) an Explainability Generator using integrated gradients and attention visualization to produce clinically interpretable saliency maps. Validated on the ADNI and AIBL datasets (N=2,847), EMDL-AD achieves 94.3% accuracy, 96.1% sensitivity, and 92.8% specificity for early AD detection, outperforming unimodal baselines by 8.7–12.4%. The framework provides transparent decision rationales, highlighting hippocampal atrophy patterns and APOE-ε4 interaction effects, thereby supporting clinician trust and personalized intervention planning.

KEYWORDS

Keywords: Alzheimer's Disease Multimodal Deep Learning Explainable AI MRI Analysis Genomic Risk Prediction Early Detection Attention Mechanisms.

Cite This Article

Naga Venkatesh Gangabathula, "Explainable Multimodal Deep Learning Framework for Early Alzheimer's Disease Detection Using MRI and Genomic Data," International Journal of Scientific Research in Engineering and Management, vol. 6, no. 8, pp. 1-5, Aug 2022. https://doi.org/10.55041/IJSREM16058

Full Article/Conclusion

We presented EMDL-AD, an explainable multimodal deep learning framework for early Alzheimer's detection integrating structural MRI and genomic data. Through a novel cross-modal attention fusion mechanism and integrated explainability tools, the framework achieves superior accuracy (94.3%) while providing clinically interpretable predictions. Validation on two independent cohorts confirms generalizability, and ablation studies validate the contribution of each architectural component. By bridging high-performance AI with clinical interpretability, EMDL-AD represents a step toward trustworthy, personalized neurodegenerative disease diagnostics.  

References

1.                Scheltens, P., et al. (2021). Alzheimer's disease. The Lancet, 397(10284), 1577-1590. 2.                Jack, C. R., et al. (2018). NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia, 14(4), 535-562. 3.                Sperling, R. A., et al. (2011). Toward defining the preclinical stages of Alzheimer's disease. Alzheimer's & Dementia, 7(3), 280-292. 4.                Karch, C. M., & Goate, A. M. (2015). Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biological Psychiatry, 77(1), 43-51. 5.                Wen, J., et al. (2020). Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation. Medical Image Analysis, 63, 101694. 6.                Escott-Price, V., et al. (2015). Polygenic risk score analysis of pathologically confirmed Alzheimer disease. Annals of Neurology, 78(2), 311-317. 7.                Tonekaboni, S., et al. (2019). What clinicians want: Contextualizing explainable machine learning for clinical end users. arXiv preprint arXiv:1905.05134. 8.                Suk, H. I., et al. (2017). Deep ensemble learning of sparse regression models for brain disease diagnosis. Medical Image Analysis, 37, 101-113. 9.                Liu, M., et al. (2020). Multimodal neuroimaging feature learning for multiclass diagnosis of Alzheimer's disease. IEEE Transactions on Medical Imaging, 39(4), 1123-1134. 10.             Chouraki, V., et al. (2017). Evaluation of a genetic risk score to improve the prediction of Alzheimer's disease risk. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 3(3), 399-408.

Editorial & Review Transparency

Publication Date

5/24/2026

Peer Review Type

Double-Blind Peer Review

Review Rounds: 2

Documents

Review Report (Confidential)
Copyright Form (Office)

Article Metrics & Impact

Article Views

0

Total views since publication

PDF Downloads

17

Total downloads since publication

Geographic Reach

5

Indexing, Archiving & Preservation

Google Scholar
Academia
ResearchGate
Crossref
SSRN
Semantic Scholar
Thomson Reuters
WorldCat
Mendeley
OpenAlex
EBSCO
Zenodo

Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.

Ethics, Compliance & Transparency

Plagiarism Screening

This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.

Conflict of Interest

The authors declare no conflict of interest related to this research work.

Funding Information

No funding information available for this research.

Similar & Recommended Articles

Similar Articles by Topic

Related research in the same subject area

Loading similar articles...